Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
IO Biotech, Inc.Listing unverified | BuyD (derivative) | $410.5K | First in 12mo | SEC | |
IO Biotech, Inc.Listing unverified | Buy | $6M | conv 70First in 12mo | SEC | |
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $65.8K | SEC | ||
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $3.1M | SEC | ||
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $299K | SEC | ||
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $2.7M | SEC | ||
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $228K | SEC | ||
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $1.1M | SEC | ||
Tarsus Pharmaceuticals, Inc.Listing on record | Sell | $12.1K | SEC |